Abstract:In occidental societies, a great number of people practice sport regularly at all ages. In this context, cartilage injury incidences have become higher and higher. They are frequently diagnosed during knee arthroscopy even in asymptomatic patients. However, patients commonly present with pain, recurrent effusion, and loss of function. Concomitantly with the increasing incidence, the expectations of patients about function restore have risen as well. Since articular cartilage is characterized by a poor intrinsic regenerative capacity, treatment of these lesions is particularly challenging.Orthopedic surgeons should face this pathology not only because it is symptomatic but also for the risk of more extensive joint damage and further degeneration of the whole articular compartment.Several therapeutic strategies have been developed, both conservative and surgical. In this chapter we will focus on infiltrative therapies, such as platelet-rich plasma (PRP), mesenchymal stem cells (MSCs), and bioengineered osteochondral scaffolds.Platelet-rich plasma (PRP) is a concentrate obtained from autologous blood containing high concentrations of human platelets and platelet-derived growth factors. They are capable of modulating the early healing response and influencing inflammation, angiogenesis, and cell migration. PRP is a safe procedure, and clinical outcome is encouraging, even if it is difficult to establish PRP efficacy because authors have used different PRP formulations, with a large inter-product variability.Another powerful tool for cartilage repair emerging in recent years is mesenchymal stem cells (MSC). Their regenerative effects are due to their immunomodulatory and anti-inflammatory action but above all to their structural contribution to tissue repair. They have a capacity for self-renewal, stemness maintenance, and the marked ability to differentiate into a variety of connective tissues. MSCs can be isolated from human sources other than the bone marrow, such as adipose tissue. Studies available suggest a potential for these cell-based treatments to be developed and to represent a promising new approach with preliminary interesting findings. Nevertheless, many aspects remain to be clarified and optimized.The awareness of the involvement of the subchondral bone in many of these lesions resulted in the need to develop cell-free treatment strategies focused on the entire osteochondral unit. Therefore, surgical techniques move on from autologous chondrocyte implantation (ACI) and autograft or allograft osteochondral implantation to new bioengineered scaffolds.Ideally, a scaffold should have the following characteristics:Three-dimensional and highly porous with an interconnected pore network for cell growth and flow transport of nutrients and metabolic waste.Biocompatible and bioresorbable with a controllable degradation and resorption rate to match cell/tissue growth in vitro and/or in vivo.Suitable surface chemistry for cell attachment, proliferation, and differentiation and mechanical properties to match those of the tissues at the site of implantation.Among them MaioRegen® and, more recently, Agili-C® have shown some of the most promising results.

Treatment of knee cartilage by cultured stem cells and three dimensional scaffold: a phase I/IIa clinical trial

Clinical Phase I/II Trial of SVF Therapy for Cartilage Regeneration: A Cellular Therapy with Novel 3D MRI Imaging for Evaluating Chondral Defect of Knee Osteoarthritis

The Restoration of Full-Thickness Cartilage Defects with Mesenchymal Stem Cells (mscs) Loaded and Cross-Linked Bilayer Collagen Scaffolds on Rabbit Model.

Comparison of the Efficacy of Human Umbilical Cord-Derived and Bone Marrow Aspirate Concentrate Mesenchymal Stem Cells for Cartilage Repair Defects of the Knee via Arthroscopic Implementation on Scaffolds in a Retrospective Study

Biological Treatment in Cartilage Injuries

Polyhydroxybutyrate/Chitosan 3D Scaffolds Promote In Vitro and In Vivo Chondrogenesis

Osteochondral repair using porous poly(lactide-co-glycolide)/nano-hydroxyapatite hybrid scaffolds with undifferentiated mesenchymal stem cells in a rat model.

Arthroscopic Implantation of a Cell-Free Bilayer Scaffold for the Treatment of Knee Chondral Lesions: A 2-Year Prospective Study

Cartilage Repair Using Mesenchymal Stem Cell (MSC) Sheet and MSCs-loaded Bilayer PLGA Scaffold in a Rabbit Model.

Novel Treatment Options for Knee Cartilage Defects in 2023

Autologous platelet-rich plasma and fibrin-augmented minced cartilage implantation in chondral lesions of the knee leads to good clinical and radiological outcomes after more than 12 months: A retrospective cohort study of 71 patients

Novel Nano-composite Multilayered Biomaterial for Osteochondral Regeneration

A Biomimetic Osteochondral Scaffold Augmented With Filtered Bone Marrow Aspirate for the Treatment of Joint Surface Lesions in the Knee

Chondrogenesis with Stem Cells in Massive Chondral Defects: A Randomized Controlled Trial

Mesenchymal stem cell-based therapy for cartilage repair: a review

Repair of injured articular and growth plate cartilage using mesenchymal stem cells and chondrogenic gene therapy

Safety and Efficacy of Kartigen® in Treating Cartilage Defects: A Randomized, Controlled, Phase I Trial

Bioprinting of Chondrocyte Stem Cell Co-Cultures for Auricular Cartilage Regeneration

Biphasic Scaffold Loaded With Autologous Cartilage Yields Better Clinical Outcome and Magnetic Resonance Imaging Filling Compared With Marrow Stimulation for Focal Osteochondral Lesions in the Knee

Matrix-Assisted Autologous Chondrocyte Transplantation for the Repair of Cartilage Defects of the Knee

Advances in cartilage tissue regeneration: a review of stem cell therapies, tissue engineering, biomaterials, and clinical trials